Patients with increased blood viscosity shown anticoagulants. In modern pharmacology has several groups, and patients want to select the best drug. Is it better or Ksarelto Cardiomagnyl? Why do I have appointed Ksarelto and sister drinking Cardiomagnyl? To get the answer to these and other similar questions, see what is said in the accompanying medicines to the instructions for use.
Ksarelto
To compare the products, it is necessary to study their characteristics. Let's start with Ksarelto.
The active ingredient - rivaroxaban. Ksarelto available in tablets of 10 mg, which take once a day, regardless of the meal.
Ease of medicine that are treated Ksarelta patient is not tedious to constantly monitor the PTV, PTI and other indicators of coagulation.
Indications for use
Ksarelto prescribed in the following cases:
- prevention of thrombosis;
- recovery from stroke and heart attack (prevention of thrombus formation);
- thromboembolism.
Ksarelto improves blood flow, reduces platelet aggregation and prevent thrombosis.
Contraindications
Take Ksarelto or other analog containing rivaroxaban is impossible when the person has:
- intolerance rivaroxaban;
- hidden internal bleeding (hemorrhage will increase);
- lactase deficiency;
- liver disease accompanied by the appearance of coagulopathy;
- pregnancy;
- breast-feeding;
- children's age (18 years).
Ksarelto - medication, past clinical testing. Its effectiveness in the prevention and treatment of thrombus encountered clinically proven. Drug means well tolerated and seldom causes side reactions.
cardiomagnil
To understand the difference between Kardiomagnilom Ksareltom and should be considered a second drug. Consider the characteristics cardiomagnyl.
Active substance - acetylsalicylic acid. Product form - tablets of 75 mg. The medication is shown once a day. But aspirin is rapidly excreted from the body and in severe thrombosis perhaps a twofold increase in prescription medications or a single dose.
testimony
Cardiomagnil in medical practice is widely used for the treatment and prevention of:
- recurrent strokes and heart attacks;
- coronary artery disease;
- angina;
- valvular insufficiency;
- atrial fibrillation;
- pulmonary embolism;
- varicose veins;
- hemorrhoids;
- thrombus formation in the early posleinsultnom and postinfarction period.
Contraindications cardiomagnyl same as for Ksarelto only added to the list propensity to allergic reactions, as well as failure of the kidneys and liver.
Cardiomagnyl Ksarelto equally and effectively treat and prevent the occurrence of blood clots, but have a different composition. In severe pathologies doctors prescribe drinking Ksarelto simultaneously Kardiomagnilom.
What gives the joint reception
Rivaroxaban does not come with aspirin in a chemical reaction, so allowed to Cardiomagnyl with Ksarelto.
The combined use provides medicaments:
- High krovorazzhizhayuschy effect;
- preventing possible overdose (this happens if Cardiomagnyl or Ksarelto assigned in high therapeutic doses);
- reducing the likelihood of side effects.
Cardiomagnyl Ksarelto and reduce platelet aggregation, inhibit the formation of intravascular thrombi and improve circulation. Take drugs together or quite alone one tool solves a doctor.
short result
Which is better and whether you can replace Ksarelto Kardiomagnilom - 2 part of the question. Look at both:
- What's better? The best is Ksarelto that, unlike cardiomagnyl, passed official tests. But Cardiomagnyl or Ksarelto - doctor selects individually.
- whether substitution is possible. Price Cardiomagnyl - 140 p, and Ksarelto stoet over 12,000 p, so the ability to replace medicines care patients with low income. Cardiomagnil - cheap medication and in some cases it is allowed to be used as a substitute Ksarelto, but to change the drug should the doctor.
Definitely say which is better - it is impossible, it is solved individually. By pharmacological qualities it considered the best Ksarelto, but its high cost is not all "afford". If there are no contraindications to aspirin therapy, the Cardiomagnyl considered "budget" option, and to appoint the majority of patients.
sources:
Vidal: https://www.vidal.ru/drugs/cardiomagnyl__35571
GRLS: https://grls.rosminzdrav.ru/Grls_View_v2.aspx? routingGuid = f69f6730-3d62-45e5-91ac-bc4e0c3b667f & t =
Found a bug? Select it and press Ctrl + Enter
